ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

ClinicalTrials.gov ID: NCT02850081

Public ClinicalTrials.gov record NCT02850081. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 7:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT02850081
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Columbia University
Other
Enrollment
31 participants

Conditions and interventions

Interventions

  • Atorvastatin Drug
  • Placebo Other
  • Statin Drug

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2017
Primary completion
Mar 30, 2020
Completion
Mar 30, 2020
Last update posted
May 6, 2026

2017 – 2020

United States locations

U.S. sites
7
U.S. states
2
U.S. cities
4
Facility City State ZIP Site status
Valley Hospital Ridgewood New Jersey 07450
Albany Medical College/The Vascular Group at Albany Albany New York 12208-3479
State University of New York at Buffalo Buffalo New York 14260-7016
New York University School of Medicine New York New York 10016-6402
Icahn School of Medicine at Mount Sinai New York New York 10029
Columbia University Medical Center New York New York 10032
Cornell University Medical College (Weill) New York New York 10065-4805

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02850081, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02850081 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →